Identification of immune-associated prognostic biomarkers in lung adenocarcinoma on the basis of gene co-expression network

References

• Jin X, Zhang B, Zhang H, et al. Smoking-associated upregulation of CBX3 suppresses ARHGAP24 expression to activate Rac1 signaling and promote tumor progression in lung adenocarcinoma. Oncogene. 2022;41(4):538–549.
   PubMed Web of Science ®Google Scholar
• Ganesh B, Devarakonda S, Govindan R. New insights into the molecular profile of lung adenocarcinoma and implications for therapy. Expert Rev Anticancer Ther. 2015;15(4):361–364.
   PubMed Web of Science ®Google Scholar
• Grizzi G, Caccese M, Gkountakos A, et al. Putative predictors of efficacy for immune checkpoint inhibitors in non-small-cell lung cancer: facing the complexity of the immune system. Expert Rev Mol Diagn. 2017;17(12):1055–1069. (2017).
   PubMed Web of Science ®Google Scholar
• Torre LA, Siegel RL, Jemal A. Lung cancer statistics. Adv Exp Med Biol. 2016;893:1–19.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA A Cancer J Clin. 2021;71(1):7–33.
   PubMed Web of Science ®Google Scholar
• Liu K, Chen S, Lu R. Identification of important genes related to ferroptosis and hypoxia in acute myocardial infarction based on WGCNA. Bioengineered. 2021;12(1):7950–7963.
   PubMed Web of Science ®Google Scholar
• Liao Y, Wang Y, Cheng M, et al. Weighted gene coexpression network analysis of features that control cancer stem cells reveals prognostic biomarkers in lung adenocarcinoma. Front Genet. 2020;11:311.
   PubMed Web of Science ®Google Scholar
• Tian Z, He W, Tang J, et al. Identification of important modules and biomarkers in breast cancer based on WGCNA. Onco Targets Ther. 2020;13:6805–6817.
   PubMed Web of Science ®Google Scholar
• Bao M, Zhang L, Hu Y. Novel gene signatures for prognosis prediction in ovarian cancer. J Cell Mol Med. 2020;24(17):9972–9984.
   PubMed Web of Science ®Google Scholar
• Oliver AJ, Lau PKH, Unsworth AS, et al. Tissue-dependent tumor microenvironments and their impact on immunotherapy responses. Front Immunol. 2018;9:70.
   PubMed Web of Science ®Google Scholar
• Gentles AJ, Newman AM, Liu CL, et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med. 2015;21(8):938–945.
   PubMed Web of Science ®Google Scholar
• Mao X, Xu J, Wang W, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20(1):131.
   PubMed Web of Science ®Google Scholar
• Zuo S, Wei M, Wang S, et al. Pan-cancer analysis of immune cell infiltration identifies a prognostic Immune-Cell Characteristic Score (ICCS) in lung adenocarcinoma. Front Immunol. 2020;11:1218.
   PubMed Web of Science ®Google Scholar
• Deng X, Lin D, Zhang X, et al. Profiles of immune-related genes and immune cell infiltration in the tumor microenvironment of diffuse lower-grade gliomas. J Cell Physiol. 2020;235(10):7321–7331.
   PubMed Web of Science ®Google Scholar
• Liao Y, He D, Wen F. Analyzing the characteristics of immune cell infiltration in lung adenocarcinoma via bioinformatics to predict the effect of immunotherapy. Immunogenetics. 2021;73(5):369–380.
   PubMed Web of Science ®Google Scholar
• Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.
   PubMed Web of Science ®Google Scholar
• Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287.
   PubMed Web of Science ®Google Scholar
• Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1–22.
   PubMed Web of Science ®Google Scholar
• Blanche P, Dartigues JF, Jacqmin-Gadda H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med. 2013;32(30):5381–5397.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Wang J, Zou K, Feng X, et al. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas. Mol Cancer. 2017;16(1):158.
   PubMedGoogle Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA A Cancer J Clin. 2019;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• He R, Zuo S. A robust 8-Gene prognostic signature for early-stage non-small cell lung cancer. Front Oncol. 2019;9:693.
   PubMed Web of Science ®Google Scholar
• Luo X, Feng L, Xu W, et al. Weighted gene co-expression network analysis of hub genes in lung adenocarcinoma. Evol Bioinform Online. 2021;17:11769343211009898.
   Web of Science ®Google Scholar
• Zhang H, Lu D, Li Q, et al. Identification of six prognostic genes in EGFR-Mutant lung adenocarcinoma using structure network algorithms. Front Genet. 2021;12:755245.
   PubMed Web of Science ®Google Scholar
• Anusewicz D, Orzechowska M, Bednarek AK. Lung squamous cell carcinoma and lung adenocarcinoma differential gene expression regulation through pathways of notch, hedgehog, wnt, and ErbB signalling. Sci Rep. 2020;10(1):21128.
   PubMedGoogle Scholar
• Ikeda J-I, Oda T, Inoue M, et al. Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung. Cancer Sci. 2009;100(3):429–433.
   PubMed Web of Science ®Google Scholar
• Ikeda J-I, Morii E, Kimura H, et al. Epigenetic regulation of the expression of the novel stem cell marker CDCP1 in cancer cells. J Pathol. 2006;210(1):75–84.
   PubMed Web of Science ®Google Scholar
• Scherl-Mostageer M, Sommergruber W, Abseher R, et al. Identification of a novel gene, CDCP1, overexpressed in human colorectal cancer. Oncogene. 2001;20(32):4402–4408.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Bo Z, Gong W, et al. Inhibitor of differentiation 1 (Id1) in cancer and cancer therapy. Int J Med Sci. 2020;17(8):995–1005.
   PubMed Web of Science ®Google Scholar
• Baraibar I, Roman M, Rodríguez-Remírez M, et al. Id1 and PD-1 combined blockade impairs tumor growth and survival of KRAS-mutant lung cancer by stimulating PD-L1 expression and tumor infiltrating CD8(+) T cells. Cancers. 2020;12(11):3169.
   PubMed Web of Science ®Google Scholar
• Huang P, Liao R, Chen X, et al. Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer. Theranostics. 2020;10(10):4644–4658.
   PubMed Web of Science ®Google Scholar
• Kang JM, Park S, Kim SJ, et al. KIAA1324 suppresses gastric cancer progression by inhibiting the oncoprotein GRP78. Cancer Res. 2015;75(15):3087–3097.
   PubMed Web of Science ®Google Scholar
• Phelan JD, Young RM, Webster DE, et al. A multiprotein supercomplex controlling oncogenic signalling in lymphoma. Nature. 2018;560(7718):387–391.
   PubMed Web of Science ®Google Scholar
• Hashimoto S, Chiorazzi N, Gregersen PK. Alternative splicing of CD79a (Ig-alpha/mb-1) and CD79b (Ig-beta/B29) RNA transcripts in human B cells. Mol Immunol. 1995;32(9):651–659.
   PubMed Web of Science ®Google Scholar
• Daley D, Mani VR, Mohan N, et al. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med. 2017;23(5):556–567.
   PubMed Web of Science ®Google Scholar
• Tone K, Stappers MHT, Willment JA, et al. C-type lectin receptors of the dectin-1 cluster: physiological roles and involvement in disease. Eur J Immunol. 2019;49(12):2127–2133.
   PubMed Web of Science ®Google Scholar
• Matsushita T. Regulatory and effector B cells: friends or foes? J Dermatol Sci. 2019;93(1):2–7.
   PubMed Web of Science ®Google Scholar